MX2007011211A - Derivados de tiazol fusionado que tienen afinidad para el receptor h3 de histamina. - Google Patents
Derivados de tiazol fusionado que tienen afinidad para el receptor h3 de histamina.Info
- Publication number
- MX2007011211A MX2007011211A MX2007011211A MX2007011211A MX2007011211A MX 2007011211 A MX2007011211 A MX 2007011211A MX 2007011211 A MX2007011211 A MX 2007011211A MX 2007011211 A MX2007011211 A MX 2007011211A MX 2007011211 A MX2007011211 A MX 2007011211A
- Authority
- MX
- Mexico
- Prior art keywords
- histamine
- affinity
- receptor
- thiazole derivatives
- fused thiazole
- Prior art date
Links
- 150000007979 thiazole derivatives Chemical class 0.000 title abstract 2
- 102000004384 Histamine H3 receptors Human genes 0.000 title 1
- 108090000981 Histamine H3 receptors Proteins 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0505205A GB0505205D0 (en) | 2005-03-14 | 2005-03-14 | Novel compounds |
| GB0525239A GB0525239D0 (en) | 2005-12-12 | 2005-12-12 | Novel compounds |
| PCT/GB2006/000846 WO2006097691A1 (en) | 2005-03-14 | 2006-03-10 | Fused thiazole derivatives having affinity for the histamine h3 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007011211A true MX2007011211A (es) | 2007-10-17 |
Family
ID=36283759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007011211A MX2007011211A (es) | 2005-03-14 | 2006-03-10 | Derivados de tiazol fusionado que tienen afinidad para el receptor h3 de histamina. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080161289A1 (enExample) |
| EP (1) | EP1858900B1 (enExample) |
| JP (1) | JP2008533117A (enExample) |
| KR (1) | KR20070113225A (enExample) |
| AT (1) | ATE420091T1 (enExample) |
| AU (1) | AU2006224440A1 (enExample) |
| BR (1) | BRPI0608437A2 (enExample) |
| CA (1) | CA2601644A1 (enExample) |
| DE (1) | DE602006004714D1 (enExample) |
| EA (1) | EA200701984A1 (enExample) |
| ES (1) | ES2321028T3 (enExample) |
| IL (1) | IL185869A0 (enExample) |
| MA (1) | MA29339B1 (enExample) |
| MX (1) | MX2007011211A (enExample) |
| NO (1) | NO20074977L (enExample) |
| WO (1) | WO2006097691A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0513886D0 (en) | 2005-07-06 | 2005-08-10 | Glaxo Group Ltd | Novel compounds |
| CA2655604C (en) | 2006-06-23 | 2016-08-09 | Abbott Laboratories | Cyclopropyl amine derivatives |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| WO2010071822A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Piperidine and piperazine derivatives and methods of use thereof |
| WO2010071819A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Bicyclic heterocyclic derivatives and methods of use thereof |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| ME02320B (me) * | 2010-09-02 | 2016-06-20 | Suven Life Sciences Ltd | Heterociklička jedinjenja kao ligandi histamin h3 receptora |
| US8853390B2 (en) | 2010-09-16 | 2014-10-07 | Abbvie Inc. | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| EP2647377A1 (en) | 2012-04-06 | 2013-10-09 | Sanofi | Use of an h3 receptor antagonist for the treatment of alzheimer's disease |
| BR112018070537B1 (pt) | 2016-04-06 | 2022-11-01 | Sumitomo Chemical Company, Limited | Composto heterocíclico, composição compreendendo o mesmo e seus usos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4324580A1 (de) * | 1993-07-22 | 1995-01-26 | Thomae Gmbh Dr K | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4427838A1 (de) | 1994-08-05 | 1996-02-08 | Thomae Gmbh Dr K | Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| JPH1017569A (ja) | 1996-07-05 | 1998-01-20 | Yamanouchi Pharmaceut Co Ltd | 置換チアゾール誘導体を有効成分とする医薬及び新規化合物 |
| EP1173438A1 (en) | 1999-04-16 | 2002-01-23 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
| GB0224083D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| WO2005009387A2 (en) | 2003-07-23 | 2005-02-03 | X-Ceptor Therapeutics Inc. | Azepine derivatives as pharmaceutical agents |
-
2006
- 2006-03-10 KR KR1020077020994A patent/KR20070113225A/ko not_active Withdrawn
- 2006-03-10 ES ES06710058T patent/ES2321028T3/es not_active Expired - Lifetime
- 2006-03-10 EA EA200701984A patent/EA200701984A1/ru unknown
- 2006-03-10 BR BRPI0608437-0A patent/BRPI0608437A2/pt not_active IP Right Cessation
- 2006-03-10 AT AT06710058T patent/ATE420091T1/de not_active IP Right Cessation
- 2006-03-10 JP JP2008501397A patent/JP2008533117A/ja not_active Withdrawn
- 2006-03-10 DE DE602006004714T patent/DE602006004714D1/de not_active Expired - Lifetime
- 2006-03-10 US US11/908,532 patent/US20080161289A1/en not_active Abandoned
- 2006-03-10 AU AU2006224440A patent/AU2006224440A1/en not_active Abandoned
- 2006-03-10 EP EP06710058A patent/EP1858900B1/en not_active Expired - Lifetime
- 2006-03-10 WO PCT/GB2006/000846 patent/WO2006097691A1/en not_active Ceased
- 2006-03-10 CA CA002601644A patent/CA2601644A1/en not_active Abandoned
- 2006-03-10 MX MX2007011211A patent/MX2007011211A/es unknown
-
2007
- 2007-09-10 IL IL185869A patent/IL185869A0/en unknown
- 2007-09-24 MA MA30235A patent/MA29339B1/fr unknown
- 2007-10-02 NO NO20074977A patent/NO20074977L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1858900A1 (en) | 2007-11-28 |
| US20080161289A1 (en) | 2008-07-03 |
| EA200701984A1 (ru) | 2008-02-28 |
| BRPI0608437A2 (pt) | 2009-12-29 |
| ES2321028T3 (es) | 2009-06-01 |
| AU2006224440A1 (en) | 2006-09-21 |
| CA2601644A1 (en) | 2006-09-21 |
| KR20070113225A (ko) | 2007-11-28 |
| WO2006097691A1 (en) | 2006-09-21 |
| ATE420091T1 (de) | 2009-01-15 |
| JP2008533117A (ja) | 2008-08-21 |
| DE602006004714D1 (de) | 2009-02-26 |
| IL185869A0 (en) | 2008-01-06 |
| EP1858900B1 (en) | 2009-01-07 |
| NO20074977L (no) | 2007-12-11 |
| MA29339B1 (fr) | 2008-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL185869A0 (en) | Fused thiazole derivatives having affinity for the histamine h3 receptor | |
| ES2299896T3 (es) | Derivados de benzazepina como antagonistas h3 de histamina. | |
| TW200500344A (en) | Novel compounds | |
| MY161834A (en) | Substituted diazepan compounds as orexin receptor antagonists | |
| TW200503713A (en) | Novel compounds | |
| TW200621716A (en) | Novel compounds | |
| TW200503710A (en) | Novel compounds | |
| CR9622A (es) | Derivados de pirazolo[3,4-d]azepina como antagonistas de histamina h3 | |
| WO2007025069A3 (en) | Diazaspirodecane orexin receptor antagonists | |
| CR11146A (es) | Antagonistas piridil piperidina del receptor de orexina | |
| GB0420831D0 (en) | Novel compounds | |
| TW200514781A (en) | Novel compounds | |
| TW200611701A (en) | Novel compounds | |
| GB0320320D0 (en) | Novel compounds | |
| MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
| WO2005097778A8 (en) | Tetrahydrobenzazepines as histamine h3 receptor ligands | |
| TW200734324A (en) | Therapeutic agents | |
| PT2016064E (pt) | Métodos para a preparação de compostos contendo pirazole | |
| SG166803A1 (en) | Novel processes for the preparation of cyclopropyl-amide derivatives | |
| TW200621255A (en) | Novel compounds |